Donald V. Daniels - Concepedia

Author

Donald V. Daniels

Roche (United States)

Also Known As

D V Daniels, D. Daniels, D.V. Daniels, Donald V Daniels, Donald V. Daniels

Publications

880

Citations

H-Index

Concepts

All Affiliations

Roche (United States)La Roche College Palo Alto Institute

About

Donald V. Daniels is an author at Roche (United States) specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	722
2	Engineering	1	1	71
3	Natural Sciences	1	1	82
4	Public Health	1	1	33
5	Allergy	1	1	43

Donald V. Daniels

Publications

859

Citations

H-Index

Page 1

	Year	Citations
Pharmacological pleiotropism of the human recombinant <i>α</i><sub>1A</sub>‐adrenoceptor: implications for <i>α</i><sub>1</sub>‐adrenoceptor classification Anthony Ford, Donald V. Daniels, David J. Chang, British Journal of Pharmacology Molecular PharmacologyUrologyMolecular PhysiologyAntagonist Affinity ProfilesEndocrine Mechanism	1997	219
<i>In vitro</i>α<sub>1</sub>‐adrenoceptor pharmacology of Ro 70–0004 and RS‐100329, novel <i>α</i><sub>1A</sub>‐adrenoceptor selective antagonists T.J. Williams, David R. Blue, Donald V. Daniels, British Journal of Pharmacology Fold SelectivityPharmacotherapyExperimental PharmacologyMolecular PharmacologyAdrenal Gland	1999	86
A single column method for the assay of adenylate cyclase Robert Alvarez, Donald V. Daniels Analytical Biochemistry Cellular EnzymologyBiochemistryMolecular Biological MethodMedicineNatural Sciences	1990	82
Molecular cloning, genomic characterization and expression of novel human α<sub>1A</sub>‐adrenoceptor isoforms David J. Chang, Thomas K. H. Chang, Susan S Yamanishi, FEBS Letters Molecular PharmacologyAdrenal GlandIdentical Splice SiteNeuroendocrine MechanismMolecular Physiology	1998	80
Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies Donald V. Daniels, Joel R. Gever, Jeffrey R. Jasper, European Journal of Pharmacology Molecular PharmacologyAdrenal GlandMedicinePhysiologyAdrenal Disease	1999	73
A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic-AMP phosphodiesterase using tritium-labeled substrates Robert Alvarez, Donald V. Daniels Analytical Biochemistry EngineeringBiochemistryTritium-labeled SubstratesBioanalysisAnalytical Chemistry	1992	71
Comparative pharmacology of recombinant human M<sub>3</sub> and M<sub>5</sub> muscarinic receptors expressed in CHO‐K1 cells N. Watson, Donald V. Daniels, Anthony Ford, British Journal of Pharmacology	1999	58
Pharmacological characteristics of Ro 115–1240, a selective α <sub>1A/1L</sub> ‐adrenoceptor partial agonist: a potential therapy for stress urinary incontinence David R. Blue, Donald V. Daniels, Joel R. Gever, British Journal of Urology	2003	49
Multiple splice variants of phosphodiesterase PDE4C cloned from human lung and testis Rena Obernolte, James Ratzliff, Preston A. Baecker, Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression AllergyHuman LungMolecular BiologyPhosphodiesterase Pde4cMultiple Splice Variants	1997	43
Beta 1-adrenergic and dopamine (D1)-receptors coupled to adenylyl cyclase activation in GT1 gonadotropin-releasing hormone neurosecretory cells. Paul R. Findell, Katie H C Wong, J K Jackman, Endocrinology NeuropeptidesCrude Particulate SuspensionsNeuroendocrine MechanismPublic HealthCyclase Activation	1993	33

Page 1